Xenogenic Collagen Matrix and Subepithelial Connective Tissue Graft in the Treatment of Gingival Recession
Launched by DAMASCUS UNIVERSITY · Sep 5, 2019
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
The aim of this study is to clinically compare between the subepithelial connective tissue graft (SCTG) plus coronally advanced flap (CAF) which is defined as the golden standard for the treatment of gingival recessions and Xenogenic collagen matrix (XCM) plus coronally advanced flap (CAF) to treat class I Miller gingival recession. CAF elevation will be done as it described by (De Sanctis \& Zucchelli 2007) with modifications in the the control group.The flap will be partially elevated in the (SCTG+CAF) group while it will be a split-full-split thickness flap in the (XCM+CAF) group, and fi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Good general health.
- • No contraindications for periodontal surgery.
- • Presence of one localized gingival recession in each side of the maxilla and/or mandible, All recessions will be Class I defects (Miller 1985).
- • The cemento-enamel junction (CEJ) is visible in the defective teeth.
- • All patients demonstrating good plaque control.
- • No previous periodontal surgery in the targeted area.
- Exclusion Criteria:
- • Smokers.
- • pregnant or nursing patients.
- • history of malignancy, radiotherapy, or chemotherapy.
- • Patients taking medications that affect mucosal healing.
- • Patients with allergy to collagen.
- • Previous participation in a clinical trial.
- • Type-1 diabetes patients.
- • Patient who have diseases that affect connective tissue metabolism.
About Damascus University
Damascus University, a prestigious institution located in Syria, is committed to advancing medical research and healthcare innovation through its clinical trial initiatives. With a focus on fostering collaboration between academia and clinical practice, the university aims to enhance the understanding of various medical conditions and improve patient outcomes. By leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, Damascus University strives to contribute to the global body of knowledge in the medical field and support the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Damascus, , Syrian Arab Republic
Patients applied
Trial Officials
Noor Alhuda Ewaz Ali, DDS
Principal Investigator
MSc student in Periodontics, University of Damascus Dental School
Suleiman Dayoub, DDS MSc PhD
Study Chair
Professor of Periodontics, University of Damascus Dental School
Mohammad Alharissy, DDS MSc PhD
Study Director
Assistant Professor of Periodontics, Academic Staff Member At Wadi International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials